Despite the setback from the trial, AstraZeneca said it would continue to analyse the complete data set, which included 210 patients, and present its results at a future medical meeting.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/TNdx8jq
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» AstraZeneca drug fails one main goal in study of chronic immune disease
https://ift.tt/1Zc3x27
No comments:
Post a Comment